or Try an Advanced Search...

    Spasms Stocks List

    Symbol Grade Name % Change
    TEVA A Teva Pharmaceutical Industries 1.65
    View As Page of Charts
    Related Industries: Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Active Pharmaceutical Ingredients Allergy Asthma Birth Control Blood Cells Bronchial Asthma Cancer Chemical Entities Cholesterol Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Contraception Drugs Fentanyl Fertility Generic Pharmaceutical Generic Pharmaceutical Products Hormones Hot Flash Immunosuppressants

    Related ETFs - A few ETFs which own one or more of the above listed Spasms stocks.

    Symbol Grade Name Weight
    ISRA D Market Vectors Israel ETF 9.1
    EIS D iShares MSCI Israel Capped Investable Market Index Fund 8.29
    PPH B Market Vectors Pharmaceutical ETF 2.85
    IZRL C ARK Israel Innovative Technology ETF 2.27
    DWMF A WisdomTree International Multifactor Fund 0.73
    View all Spasms ETFs...
    Compare ETFs
    Compare ISRA to DWMF Compare ISRA to EIS Compare PPH to IZRL

        Spasms Stocks Recent News

        Date Stock Title
        May 9 TEVA Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        May 9 TEVA Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results
        May 9 TEVA Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
        May 9 TEVA Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade)
        May 8 TEVA Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
        May 8 TEVA Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Call Transcript
        May 8 TEVA Teva hits a five-year high on schizophrenia trial win, Q1 beat
        May 8 TEVA Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
        May 8 TEVA Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter
        May 8 TEVA Teva Pharmaceutical Industries Limited 2024 Q1 - Results - Earnings Call Presentation
        May 8 TEVA UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue risea
        May 8 TEVA Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy
        May 8 TEVA Teva Pharm Q1 profit misses estimates, revenue risea
        May 8 TEVA Teva Pharmaceutical reports mixed Q1 results; reaffirms FY24 outlook
        May 8 TEVA Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
        May 8 TEVA Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
        May 8 TEVA Investor Sentiment Falls Further, Dow Gains For Fifth Session
        May 8 TEVA Uber, Lyft And 3 Stocks To Watch Heading Into Wednesday
        May 7 TEVA Teva Earnings Are Soon. What Could Keep the Stock Gains Going.
        May 7 TEVA 20 States with the Highest Fertility Rates in the US
        Related Industries: Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Active Pharmaceutical Ingredients Allergy Asthma Birth Control Blood Cells Bronchial Asthma Cancer Chemical Entities Cholesterol Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Contraception Drugs Fentanyl Fertility Generic Pharmaceutical Generic Pharmaceutical Products Hormones Hot Flash Immunosuppressants
        Spasms

        Spasms is a 1983 Canadian horror film directed by William Fruet and starring Peter Fonda, Oliver Reed, and Kerrie Keane. It is based on the 1979 novel Death Bite by Michael Maryk and Brent Monahan.
        According to Filmink the movie "kicked off his [Fonda's] straight to video phase that lasted through the ‘80s."

        More about Spasms
        Browse All Tags